David Schopfer, MD

169 posts

David Schopfer, MD banner
David Schopfer, MD

David Schopfer, MD

@schopfermd

Cardiologist seeking better ways to improve CV health with clinical trials and health services & outcomes research

Chevy Chase, MD Beigetreten Eylül 2008
447 Folgt141 Follower
David Schopfer, MD
David Schopfer, MD@schopfermd·
@tmodarressi These are not primary prevention patients. Prior CABG? Multivessel PCI? Diabetes with retinopathy? Multiple vascular bed involvement? These patients are sicker than in FOURIER.
English
0
0
3
141
Taher Modarressi, MD, FNLA
Taher Modarressi, MD, FNLA@tmodarressi·
VESALIUS a star of this lipid session at #AHA25. Substantial and deeply clinically meaningful benefit w Repatha in primary prevention. Baseline LDL-C 122. Notable ARRs, and 20% decrease in all-cause mortality! #AHA25
Taher Modarressi, MD, FNLA tweet mediaTaher Modarressi, MD, FNLA tweet mediaTaher Modarressi, MD, FNLA tweet mediaTaher Modarressi, MD, FNLA tweet media
English
7
11
38
31.4K
David Schopfer, MD
David Schopfer, MD@schopfermd·
@khurramn1 Agreed. These patients are Not primary prevention and had extensive and severe disease. Arguably sicker and higher risk than the original FOURIER cohort.
English
1
0
1
142
Khurram Nasir
Khurram Nasir@khurramn1·
I think we should be providing a disclaimer “very high risk” 33% had prior coronary revasc, 10% severe carotid disease or revasc, and 10% demonstrated PAD. It’s not a primary prevention trial
Taher Modarressi, MD, FNLA@tmodarressi

VESALIUS a star of this lipid session at #AHA25. Substantial and deeply clinically meaningful benefit w Repatha in primary prevention. Baseline LDL-C 122. Notable ARRs, and 20% decrease in all-cause mortality! #AHA25

English
11
12
103
17.1K
David Schopfer, MD
David Schopfer, MD@schopfermd·
@drpablocorral These are not primary prevention patients. Inclusion criteria so strict most of these had more severe atherosclerotic disease than in FOURIER.
English
1
2
8
454
Pablo Corral MD
Pablo Corral MD@drpablocorral·
🚨 New breakthrough in prevention! 👉In the VESALIUS‑CV trial, Evolocumab added to high-intensity statin therapy reduced major adverse cardiovascular events (MACE) by 25% (HR 0.75; 95% CI 0.65-0.86) over ~4.6 years in patients who had no prior MI or stroke. 👉Absolute risk reductions: • ~1.8% for death from coronary disease, MI, or stroke. • ~2.8% when adding ischemia-driven revascularisation. 👉LDL-C fell ~55% to ~45 mg/dL—highlighting once again that “lower is better”, even before a first event. ☝️What this means for clinical practice: • This is the first PCSK9 inhibitor trial showing benefit in a “pre–first event” high-risk population, not just secondary prevention. • Identifying high-risk patients (e.g., established atherosclerosis, high-risk diabetes) before MI or stroke is crucial. • This supports aggressive LDL-C lowering to ~40 mg/dL in selected patients—even without prior event history. ☝️Take-home: For the right high-risk patient, adding evolocumab before the first major cardiovascular event can be a game-changer. Traditional prevention meets cutting-edge therapy. @society_eas nejm.org/doi/full/10.10…
Pablo Corral MD tweet media
English
19
79
216
55.7K
Maximiliano Bretos
Maximiliano Bretos@MaxBretosSports·
Interesting situation.. you obviously take the advantage and goal, but free kick and red card to Leon Bailey might be after 90 mins better route to win!! 🤔
English
16
5
48
14.3K
M. Nolan Gray 🥑
M. Nolan Gray 🥑@mnolangray·
What's the most underrated city in California?
Colorado, USA 🇺🇸 English
80
5
51
0
David Schopfer, MD retweetet
Robert Reich
Robert Reich@RBReich·
Serious question: Why on earth should Manchin be in charge of the Senate Energy and Natural Resources Committee? He’s taken more money from fossil fuel sources than any other member of Congress, including every Republican. Hello?
English
126
656
2.1K
0
David Schopfer, MD retweetet
Team Katie
Team Katie@TeamKatiePorter·
Big Pharma says they need to charge astronomical prices to pay for research and development. Yet, the amount they spend on manipulating the market to enrich shareholders completely eclipses what's spent on R&D. Today, I confronted a CEO about the industry's lies, with visuals ⤵️
English
6.7K
51.2K
176.9K
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
McConnell: "We can't consider impeachment before Trump leaves office." McConnell: "We can't consider impeachment because Trump already left office."
English
0
0
1
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
NHLBI announced upcoming research opportunities to investigate post-acute sequelae of COVID-19 (aka "Long COVID") in people who were infected and are suffering a variety of symptoms. Solicitations for research forthcoming. covid19.nih.gov/sites/default/…
English
0
0
0
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
@OpenMCPS The lack of science in their decision-making is appalling. Schools all over are doing it well and proving it is possible.
English
1
1
4
0
TogetherAgainMCPS
TogetherAgainMCPS@OpenMCPS·
Seems like state teachers' union has their own plans for return to school despite the prioritization of teachers for vaccine distribution. "Bost says late summer or early fall may be a more realistic time frame." wcbcradio.com/?news=hogan-no…
TogetherAgainMCPS tweet media
English
4
1
5
0
Tesla Raj
Tesla Raj@tesla_raj·
@elonmusk @p_ferragu Also an option to transfer our FSD to our next car would be perfect. I’d buy a Model Y today!
English
44
10
572
0
Pierre Ferragu
Pierre Ferragu@p_ferragu·
@elonmusk: I paid FSD for my Model 3 in November. I now want to upgrade to model Y and your team tells me you don't value FSD in your trade-in offer because you can do the software upgrade for free. Want me to pay again full price for FSD again? That's not fair, change that!
English
409
276
4.8K
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
@BethesdaBeat MCPS is not opening this school year, much less next month. The metrics they have set are WAY BEYOND what we can reach any time soon. Fingers crossed for September, but that is no guarantee either.
English
1
0
0
0
Bethesda Magazine | Bethesda Today
Absent an unexpected reversal of the worsening COVID-19 data, or a change to the metrics set to guide MCPS reopening, buildings will likely not reopen as planned next month. ow.ly/F7fH50D1YHc
English
1
0
7
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
Pipe bombs found and destroyed at headquarters of RNC and DNC. Is that a 1st amendment right? Is this officially considered a coup attempt yet?
English
0
1
3
0
David Schopfer, MD
David Schopfer, MD@schopfermd·
We do a better job protecting confederate statues than we do the Capitol Building.
English
0
0
1
0
David Schopfer, MD retweetet
Judd Legum
Judd Legum@JuddLegum·
In America, you can be teargassed and shot with rubber bullets for peacefully protesting in front of a church. But you can literally bust down the doors to the United States Capitol and stroll around while police officers watch.
Judd Legum tweet mediaJudd Legum tweet media
English
438
18.1K
36.4K
0
David Schopfer, MD retweetet
Patrick S. Tomlinson
Patrick S. Tomlinson@stealthygeek·
Stop sharing the McConnell quote from 2016 about "The American People" having a voice in picking a new SCOTUS Justice. Just stop it. He doesn't care. He didn't care then, he sure as fuck doesn't care now. He's a traitor. He feels no shame, no pity, nothing. End the GOP.
English
9
68
282
0
David Schopfer, MD retweetet
Maya Harris
Maya Harris@mayaharris_·
That day when a little girl from Oaktown became the first black woman to be a major-party vice-presidential nominee...😭 So incredibly proud of you, sis! ❤️🤍💙
Maya Harris tweet media
English
1.1K
9.8K
98.5K
0
David Schopfer, MD retweetet
NYT Health
NYT Health@NYTHealth·
A medical group known as conservative and cautious has a clear message: Get kids back into classrooms this fall, even if 6 feet of distance can't be maintained. Dr. Sean O'Leary explains why.  nyti.ms/2YRfxbd
English
3
11
35
0
David Schopfer, MD retweetet
ESPN FC
ESPN FC@ESPNFC·
LIVERPOOL HAVE WAITED 30 YEARS FOR THIS MOMENT! THEY ARE PREMIER LEAGUE CHAMPIONS 🏆
ESPN FC tweet media
English
60
1.8K
6.1K
0